Category: Sanofi-AventisSyndicate content

Report: Smith & Nephew CEO Bohoun to stay put

December 1, 2014 by Brad Perriello

Smith & Nephew CEO Olivier Bohuon reportedly tells employees that he's not in the running for the top job at French drug maker Sanofi.

Report: Smith & Nephew CEO Bohoun to stay put

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Smith & Nephew's Bohuon seen as strong candidate for top Sanofi job

November 4, 2014 by MassDevice

Smith & Nephew CEO Olivier Bohuon is said to be a leading candidate for the top job at French drugmaker Sanofi, which axed its CEO last week without a replacement.

YYmeta

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Diabetes: Medtronic and Sanofi ally on new drug-device combinations

June 16, 2014 by Arezu Sarvestani

Medtronic and Sanofi embark on a global alliance to combine human and financial resources in the interest of new products and services for patients with diabetes.

Diabetes: Medtronic and Sanofi ally for drug-device combinations

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Whistleblower lawsuit costs Genzyme $22M

January 3, 2014 by Arezu Sarvestani

Sanofi subsidiary Genzyme agrees to pay $22.3 million to settle accusations that its sales rep encouraged off-label use of the Seprafilm surgical product.

Whistleblower lawsuit costs Genzyme $22M

Massachusetts-based Genzyme Corp., a subsidiary of Sanofi (NYSE:SNY), agreed to pay $22.3 million to settle a whistleblower lawsuit accusing the company of off-label marketing of its Seprafilm surgical product.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Brokers plead guilty to insider trading of Stryker stock

November 14, 2013 by Brad Perriello

A pair of brokers plead guilty to charges of insider trading in Stryker Corp. stock ahead of its 2011 acquisition of Orthovita.

Brokers plead guilty to insider trading of Stryker stock

A pair of brokers pleaded guilty to federal insider trading charges yesterday, admitting that they used tips from a former Stryker (NYSE:SYK) marketing executive to make illicit trades ahead of the medical device company's 2011 acquisition of Orthovita.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Unilife shares surge on MedImmune deal

November 13, 2013 by Chris Walker

Unilife shares are up more than 24% this week on news of a deal with MedImmune, the biologics arm of pharmaceuticals giant AstraZeneca.

Unilife shares surge on MedImmune Deal

Unilife (NSDQ:UNIS) shares are up more than 24% this week on a supply deal for its wearable injectors it inked with MedImmune, the biologics division of pharma giant AstraZeneca (NYSE:AZN).

Forbes articles were a 'vindictive attack on me personally,' says Unilife CEO

September 12, 2013 by Arezu Sarvestani

Unilife CEO Alan Shortall says a pair of Forbes articles were "vindictive," "malicious" and a "slap in the face" to analysts and portfolio managers who put their trust in the company.

Unilife takes issue with Forbes article on whistleblower lawsuit
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp